Compile Data Set for Download or QSAR
maximum 50k data
Found 125 with Last Name = 'rockwell' and Initial = 'al'
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50058855((S)-2-Butoxycarbonylamino-3-{2-[(R)-3-(4-carbamimi...)
Affinity DataIC50:  0.25nMAssay Description:Inhibition of [125I]fibrinogen binding to purified platelet Fibrinogen ReceptorMore data for this Ligand-Target Pair
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50076575(3-{5-[4-amino(imino)methylaminobutyl]-4,5-dihydro-...)
Affinity DataIC50:  0.700nMAssay Description:Antagonistic activity against vitronectin receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50217532(CHEMBL3559597)
Affinity DataIC50:  2nMAssay Description:Antagonistic activity against vitronectin receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50076582(3-{5-[4-amino(imino)methylaminobutyl]-4,5-dihydro-...)
Affinity DataIC50:  4nMAssay Description:Antagonistic activity against vitronectin receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50217533(CHEMBL3559598)
Affinity DataIC50:  7nMAssay Description:Antagonistic activity against fibrinogen receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50076576(3-{5-[4-amino(imino)methylaminobutyl]-4,5-dihydro-...)
Affinity DataIC50:  8nMAssay Description:Antagonistic activity against vitronectin receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50058855((S)-2-Butoxycarbonylamino-3-{2-[(R)-3-(4-carbamimi...)
Affinity DataIC50:  11nMAssay Description:Inhibition of [125I]fibrinogen binding to activated human plateletsMore data for this Ligand-Target Pair
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50076565(3-{5-[4-amino(imino)methylaminobutyl]-4,5-dihydro-...)
Affinity DataIC50:  11nMAssay Description:Antagonistic activity against fibrinogen receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50076560(3-{5-[4-amino(imino)methylaminobutyl]-4,5-dihydro-...)
Affinity DataIC50:  12nMAssay Description:Antagonistic activity against fibrinogen receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50076588(3-{5-[4-amino(imino)methylaminobutyl]-4,5-dihydro-...)
Affinity DataIC50:  12nMAssay Description:Antagonistic activity against vitronectin receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50076561(3-{5-[4-amino(imino)methylaminobutyl]-4,5-dihydro-...)
Affinity DataIC50:  14nMAssay Description:Antagonistic activity against vitronectin receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50076584(3-{5-[4-amino(imino)methylaminobutyl]-4,5-dihydro-...)
Affinity DataIC50:  15nMAssay Description:Antagonistic activity against vitronectin receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50076570(3-{5-[4-amino(imino)methylaminobutyl]-4,5-dihydro-...)
Affinity DataIC50:  16nMAssay Description:Antagonistic activity against fibrinogen receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50076569((S)-2-Benzyloxycarbonylamino-3-{[5-(4-guanidino-bu...)
Affinity DataIC50:  23nMAssay Description:Antagonistic activity against vitronectin receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50076559(3-{5-[4-amino(imino)methylaminobutyl]-4,5-dihydro-...)
Affinity DataIC50:  23nMAssay Description:Antagonistic activity against fibrinogen receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50076562(3-{5-[4-amino(imino)methylaminobutyl]-4,5-dihydro-...)
Affinity DataIC50:  24nMAssay Description:Antagonistic activity against vitronectin receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50058889((R)-2-Butoxycarbonylamino-3-{2-[(R)-3-(4-carbamimi...)
Affinity DataIC50:  27nMAssay Description:In vitro inhibition of ADP-induced platelet aggregation in human platelet rich plasma (hPRP)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50058900((S)-2-Butoxycarbonylamino-3-{2-[3-(4-carbamimidoyl...)
Affinity DataIC50:  30nMAssay Description:In vitro inhibition of ADP-induced platelet aggregation in human platelet rich plasma (hPRP)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50058848((S)-3-{2-[3-(4-Carbamimidoyl-phenyl)-4,5-dihydro-i...)
Affinity DataIC50:  31nMAssay Description:In vitro inhibition of ADP-induced platelet aggregation in human platelet rich plasma (hPRP)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50058847((S)-3-{2-[3-(4-Carbamimidoyl-phenyl)-4,5-dihydro-i...)
Affinity DataIC50:  31nMAssay Description:In vitro inhibition of ADP-induced platelet aggregation in human platelet rich plasma (hPRP)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50058881((S)-2-(Butane-1-sulfonylamino)-3-{2-[3-(4-carbamim...)
Affinity DataIC50:  31nMAssay Description:In vitro inhibition of ADP-induced platelet aggregation in human platelet rich plasma (hPRP)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50058866((S)-3-{2-[3-(4-Carbamimidoyl-phenyl)-4,5-dihydro-i...)
Affinity DataIC50:  32nMAssay Description:In vitro inhibition of ADP-induced platelet aggregation in human platelet rich plasma (hPRP)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50058853((S)-3-{2-[3-(4-Carbamimidoyl-phenyl)-4,5-dihydro-i...)
Affinity DataIC50:  32nMAssay Description:In vitro inhibition of ADP-induced platelet aggregation in human platelet rich plasma (hPRP)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50058858((R)-2-Butoxycarbonylamino-3-{2-[(S)-3-(4-carbamimi...)
Affinity DataIC50:  32nMAssay Description:In vitro inhibition of ADP-induced platelet aggregation in human platelet rich plasma (hPRP)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50058880((S)-3-{2-[3-(4-Carbamimidoyl-phenyl)-4,5-dihydro-i...)
Affinity DataIC50:  36nMAssay Description:In vitro inhibition of ADP-induced platelet aggregation in human platelet rich plasma (hPRP)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50076573(3-{5-[4-amino(imino)methylaminobutyl]-4,5-dihydro-...)
Affinity DataIC50:  36nMAssay Description:Antagonistic activity against vitronectin receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50058870((S)-3-{2-[3-(4-Carbamimidoyl-phenyl)-4,5-dihydro-i...)
Affinity DataIC50:  41nMAssay Description:In vitro inhibition of ADP-induced platelet aggregation in human platelet rich plasma (hPRP)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50058871((S)-2-Butoxycarbonylamino-3-{2-[3-(4-carbamimidoyl...)
Affinity DataIC50:  42nMAssay Description:In vitro inhibition of ADP-induced platelet aggregation in human platelet rich plasma (hPRP)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50058892((S)-2-(4-Bromo-benzyloxycarbonylamino)-3-{2-[3-(4-...)
Affinity DataIC50:  44nMAssay Description:In vitro inhibition of ADP-induced platelet aggregation in human platelet rich plasma (hPRP)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50058883((S)-2-But-3-enyloxycarbonylamino-3-{2-[3-(4-carbam...)
Affinity DataIC50:  44nMAssay Description:In vitro inhibition of ADP-induced platelet aggregation in human platelet rich plasma (hPRP)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50058851((S)-3-{2-[3-(4-Carbamimidoyl-phenyl)-4,5-dihydro-i...)
Affinity DataIC50:  47nMAssay Description:In vitro inhibition of ADP-induced platelet aggregation in human platelet rich plasma (hPRP)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50058864((S)-2-Benzyloxycarbonylamino-3-{2-[3-(4-carbamimid...)
Affinity DataIC50:  47nMAssay Description:In vitro inhibition of ADP-induced platelet aggregation in human platelet rich plasma (hPRP)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50058863((S)-3-{2-[3-(4-Carbamimidoyl-phenyl)-4,5-dihydro-i...)
Affinity DataIC50:  49nMAssay Description:In vitro inhibition of ADP-induced platelet aggregation in human platelet rich plasma (hPRP)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50058855((S)-2-Butoxycarbonylamino-3-{2-[(R)-3-(4-carbamimi...)
Affinity DataIC50:  50nMAssay Description:In vitro inhibition of ADP-induced platelet aggregation in human platelet rich plasma (hPRP)More data for this Ligand-Target Pair
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50058856((R)-3-{2-[3-(4-Carbamimidoyl-phenyl)-4,5-dihydro-i...)
Affinity DataIC50:  50nMAssay Description:In vitro inhibition of ADP-induced platelet aggregation in human platelet rich plasma (hPRP)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50058852((R)-3-{2-[(R)-3-(4-Carbamimidoyl-phenyl)-4,5-dihyd...)
Affinity DataIC50:  54nMAssay Description:In vitro inhibition of ADP-induced platelet aggregation in human platelet rich plasma (hPRP)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50058897((S)-3-{2-[3-(4-Carbamimidoyl-phenyl)-4,5-dihydro-i...)
Affinity DataIC50:  55nMAssay Description:In vitro inhibition of ADP-induced platelet aggregation in human platelet rich plasma (hPRP)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50055900(3-{2-[(R)-3-(4-Carbamimidoyl-phenyl)-4,5-dihydro-i...)
Affinity DataIC50:  60nMAssay Description:In vitro inhibition of ADP-induced platelet aggregation in human platelet rich plasma (hPRP)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50058861((S)-3-{2-[3-(4-Carbamimidoyl-phenyl)-4,5-dihydro-i...)
Affinity DataIC50:  61nMAssay Description:In vitro inhibition of ADP-induced platelet aggregation in human platelet rich plasma (hPRP)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50058884((S)-3-{2-[3-(4-Carbamimidoyl-phenyl)-4,5-dihydro-i...)
Affinity DataIC50:  65nMAssay Description:In vitro inhibition of ADP-induced platelet aggregation in human platelet rich plasma (hPRP)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50076581((S)-2-Benzyloxycarbonylamino-3-{[5-(2-guanidino-et...)
Affinity DataIC50:  66nMAssay Description:Antagonistic activity against vitronectin receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50058896((S)-2-[(Biphenyl-4-carbonyl)-amino]-3-{2-[3-(4-car...)
Affinity DataIC50:  67nMAssay Description:In vitro inhibition of ADP-induced platelet aggregation in human platelet rich plasma (hPRP)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50058874((S)-2-(3-Benzyl-ureido)-3-{2-[3-(4-carbamimidoyl-p...)
Affinity DataIC50:  67nMAssay Description:In vitro inhibition of ADP-induced platelet aggregation in human platelet rich plasma (hPRP)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50058868((S)-3-{2-[3-(4-Carbamimidoyl-phenyl)-4,5-dihydro-i...)
Affinity DataIC50:  68nMAssay Description:In vitro inhibition of ADP-induced platelet aggregation in human platelet rich plasma (hPRP)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50058877((S)-3-{2-[3-(4-Carbamimidoyl-phenyl)-4,5-dihydro-i...)
Affinity DataIC50:  69nMAssay Description:In vitro inhibition of ADP-induced platelet aggregation in human platelet rich plasma (hPRP)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50076557((S)-2-Benzyloxycarbonylamino-3-{2-[3-(3-guanidino-...)
Affinity DataIC50:  72nMAssay Description:Antagonistic activity against vitronectin receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50058882((S)-2-Butoxycarbonylamino-3-{2-[3-(4-carbamimidoyl...)
Affinity DataIC50:  73nMAssay Description:In vitro inhibition of ADP-induced platelet aggregation in human platelet rich plasma (hPRP)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50058871((S)-2-Butoxycarbonylamino-3-{2-[3-(4-carbamimidoyl...)
Affinity DataIC50:  75nMAssay Description:In vitro inhibition of ADP-induced platelet aggregation in human platelet rich plasma (hPRP)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50058867((R)-3-{2-[3-(4-Carbamimidoyl-phenyl)-4,5-dihydro-i...)
Affinity DataIC50:  78nMAssay Description:In vitro inhibition of ADP-induced platelet aggregation in human platelet rich plasma (hPRP)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50076563((S)-2-Benzyloxycarbonylamino-3-{3-[5-(2-guanidino-...)
Affinity DataIC50:  87nMAssay Description:Antagonistic activity against fibrinogen receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Displayed 1 to 50 (of 125 total ) | Next | Last >>
Jump to: